Screener
Vir Biotechnology, Inc. VIR Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Intangible assets, net | 7,702 | 7,850 |
| Goodwill | 16,937 | 16,937 |
| Property and equipment, net | 50,430 | 55,620 |
| Operating right-of-use assets | 59,391 | 62,099 |
| Restricted cash and cash equivalents, noncurrent | 6,944 | 6,963 |
| Long-term investments | 475,016 | 314,575 |
| Other assets | 24,647 | 24,699 |
| TOTAL ASSETS | $1,214,806 | $1,002,823 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s operating lease ROU assets?
- Vir Biotechnology, Inc. (VIR) reported operating lease ROU assets of $59.39M in Q2 2026.
- How has Vir Biotechnology, Inc.'s operating lease ROU assets changed year-over-year?
- Vir Biotechnology, Inc.'s operating lease ROU assets decreased by 8.4% year-over-year, from $64.85M to $59.39M.
- What is the long-term trend for Vir Biotechnology, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s operating lease ROU assets has grown at a 0.0% compound annual growth rate (CAGR), from $61.95M to $62.1M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Vir Biotechnology, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude